Improving the Infectious Diseases Physician Scientist Workforce From the View of Junior Investigators: Vision, Transparency, and Reproducibility.
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco.
- Published Article
Clinical Infectious Diseases
Oxford University Press
- Publication Date
Jan 01, 2020
Shortcomings in the current pipeline of infectious disease physician scientists are well documented. With a focus on the transition of early stage investigators to research independence, we outline challenges in existing training pathways for physician scientists. We urge leaders of infectious disease societies, divisions, and governmental and nongovernmental funding organizations to reinvigorate a vision for nurturing trainees with interests in research, to seek transparency in physician scientist funding mechanisms, and to encourage efforts to improve the reproducibility of outcomes for talented junior investigators. We feel that the alternative to making these changes will lead to further drop-off in the physician scientist pipeline in a field that has a perpetual need for research. © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 03/19/2020 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/31231765